Holen Sie sich die Stockscreener-App
2.12
1.40%
-0.03
Handel nachbörslich:
2.11
-0.01
-0.47%
Schlusskurs vom Vortag:
$2.15
Offen:
$2.17
24-Stunden-Volumen:
61,152
Relative Volume:
0.89
Marktkapitalisierung:
$86.59M
Einnahmen:
$2.70M
Nettoeinkommen (Verlust:
$5.53M
KGV:
19.27
EPS:
0.11
Netto-Cashflow:
$-10.55M
1W Leistung:
-1.85%
1M Leistung:
+0.95%
6M Leistung:
-5.36%
1J Leistung:
-10.55%
1-Tages-Spanne:
$2.08
$2.18
1-Wochen-Bereich:
$2.08
$2.26
52-Wochen-Spanne:
$1.82
$3.09
Oramed Pharmaceuticals Inc Stock (ORMP) Company Profile
Firmenname
Oramed Pharmaceuticals Inc
Sektor
Branche
Telefon
646-844-1164
Adresse
1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK, NY
Vergleichen Sie ORMP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ORMP
Oramed Pharmaceuticals Inc
|
2.12 | 87.82M | 2.70M | 5.53M | -10.55M | 0.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Oramed Pharmaceuticals Inc Stock (ORMP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-01-12 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2022-02-18 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-04-20 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-02-09 | Eingeleitet | National Securities | Buy |
| 2020-12-03 | Eingeleitet | Alliance Global Partners | Buy |
| 2020-03-11 | Eingeleitet | Aegis Capital | Buy |
| 2019-09-11 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2017-12-11 | Fortgesetzt | B. Riley FBR, Inc. | Buy |
| 2016-05-26 | Bestätigt | FBR Capital | Outperform |
| 2015-12-01 | Bestätigt | H.C. Wainwright | Buy |
| 2015-11-19 | Eingeleitet | FBR Capital | Outperform |
| 2015-04-13 | Fortgesetzt | MLV & Co | Buy |
| 2014-01-30 | Bestätigt | Aegis Capital | Buy |
| 2014-01-08 | Bestätigt | Aegis Capital | Buy |
| 2014-01-08 | Eingeleitet | MLV & Co | Buy |
| 2013-12-03 | Eingeleitet | Aegis Capital | Buy |
Alle ansehen
Oramed Pharmaceuticals Inc Aktie (ORMP) Neueste Nachrichten
What are the latest earnings results for Oramed Pharmaceuticals Inc.Value Investing Review From AI Tools - jammulinksnews.com
What are analysts’ price targets for Oramed Pharmaceuticals Inc. in the next 12 monthsAI Powered Ideas With High Returns - jammulinksnews.com
How high can Oramed Pharmaceuticals Inc. stock goAI Swing Strategy Signal Forecasting System - Newser
Is Oramed Pharmaceuticals Inc. stock overvalued or undervaluedAI Powered Ideas With High Returns - jammulinksnews.com
Diabetes Pipeline 2025: Therapies Under Investigation, - openPR.com
Key External Factors That Drive Oramed Pharmaceuticals Inc. Stock Price MovementsConsistent Return Setup with Exit Strategy - Newser
How high can Oramed Pharmaceuticals Inc. stock price go in 2025Trend Following Ideas with Volume Confirmation - Newser
What are the technical indicators suggesting about Oramed Pharmaceuticals Inc.Advanced Screener Entry Points For Consistent Profits - jammulinksnews.com
How does Oramed Pharmaceuticals Inc. generate profit in a changing economyAI Powered Review For 2025 - jammulinksnews.com
Published on: 2025-07-30 11:09:17 - metal.it
What makes Oramed Pharmaceuticals Inc. stock price move sharplyHigh Reward Picks with Tight Risk Control - Newser
Published on: 2025-07-29 17:32:00 - metal.it
Oramed Pharmaceuticals Inc. Stock Support and Resistance Levels You Should KnowMulti-Bagger Detection with Trend Tools - Newser
Published on: 2025-07-28 21:44:50 - metal.it
What Technical Tools Say About Oramed Pharmaceuticals Inc. RecoveryWeekly Watchlist of High Movers Released - metal.it
How volatile is Oramed Pharmaceuticals Inc. stock compared to the marketGet daily expert analysis for smarter investing - jammulinksnews.com
Should I hold or sell Oramed Pharmaceuticals Inc. stock in 2025Capitalize on emerging market opportunities - jammulinksnews.com
Is it the right time to buy Oramed Pharmaceuticals Inc. stockExceptional stock performance - jammulinksnews.com
How high can Oramed Pharmaceuticals Inc. stock price go in 2025 Smart Chart Forecasting with AI Algorithms - Newser
Can a trend reversal in Oramed Pharmaceuticals Inc. lead to recovery Weekly Chart-Based Forecast for Traders - Newser
What is the dividend policy of Oramed Pharmaceuticals Inc. stockConsistent triple-digit returns - jammulinksnews.com
How does Oramed Pharmaceuticals Inc. compare to its industry peersGet daily expert analysis on top stocks - jammulinksnews.com
When is Oramed Pharmaceuticals Inc. stock expected to show significant growthUnlock expert market analysis instantly - jammulinksnews.com
Intrinsic Value of Oramed Pharmaceuticals Inc. Stock: Is It Undervalued or OvervaluedFree Stock Market Practical Discussion Forums - Newser
Oramed Pharmaceuticals Inc. Earnings Report Breakdown: What Investors Should KnowFree High-Accuracy Stock Picks - Newser
What analysts say about Oramed Pharmaceuticals Inc. stock outlookFree Stock Market Real-Time Monitoring - jammulinksnews.com
What drives Oramed Pharmaceuticals Inc. stock priceBreakout portfolio performance - Autocar Professional
How Oramed Pharmaceuticals Inc. stock reacts to Fed policy changesFree Trading Psychology Coaching - jammulinksnews.com
What analysts say about Oramed Pharmaceuticals Inc. stockFree Popular Stock Recommendations - Autocar Professional
Oramed Pharmaceuticals Inc. Stock Analysis and ForecastSky-high return potential - Autocar Professional
Oramed Pharm and Scilex Finalize Option Agreement - TipRanks
Oramed Pharmaceuticals enters option agreement with Scilex for warrant repurchase - MarketScreener
Finanzdaten der Oramed Pharmaceuticals Inc-Aktie (ORMP)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.93%
0.15%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):